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INTRODUCTION 
 Hypertension is a very common disorder especially past middle 
age. It is not a disease in itself, but is an important risk factor for 
coronary, cerebral, renal and peripheral vascular disease. (1) Of all 
hypertensive patients, majority of cases are of essential hypertension 
which accounts for about 90% of total hypertensive population. (2) 
 Risk factors for hypertension incidence include genetic 
predisposition, age, sex, BMI, smoking, alcoholism and lifestyle factors. 
Among lifestyle factors, high dietary sodium and low potassium intakes 
were found to be associated with blood pressure in many studies. (3) (4) 
 The large Intersalt study showed that high sodium intake was 
directly related to blood pressure while low potassium intake was 
inversely and independently related to the same. (3)A positive correlation 
was observed between urinary Na+/K+molar ratio and blood pressure. (5) 
 Guyton states that increased blood pressure is required to maintain 
renal sodium excretion and sodium balance in essential hypertension. (6) 
 Our present study was based on Guyton’s hypothesis and aimed at 
studying the association between 24 hour urinary sodium and  potassium 
excretion with blood pressure. 
 
 
DEFINITION &CLASSIFICATION 
DEFINITION 
 Hypertension is arbitrarily defined as sustained systolic blood 
pressure of 140 mmHg or greater and a diastolic BP of 90 mmHg or 
greater or by virtue of the patient taking antihypertensive medications. (7) 
CLASSIFICATION 
Classification of Blood pressure (7) for adults aged 18 years or older 
         Category   Systolic BP (mmHg)  Diastolic BP(mmHg) 
 Normal             <120        and <80 
 Prehypertension            120 - 139       or  80 - 89 
 Stage 1 hypertension            140 - 159       or  90 - 99 
 Stage 2 hypertension             ≥ 160       or   ≥100 
 
This classification should be based on the mean of two or more 
blood pressure readings at each of two or more visits after the initial 
screening. 
When systolic BP and diastolic BP fall into different categories,the 
higher category should be selected to classify the individual’s BP.  
 
 
EPIDEMIOLOGY 
 Hypertension is present globally but its prevalence varies among 
different countries and sub populations.Worldwide more than one billion 
individuals have hypertension. 
 Data from the National Health and Nutrition Examination Survey 
(NHANES 1999 to 2000) showed that approximately 31.3% of adult 
population in United States has hypertension. 
In the Indian subcontinent, there are no well co-ordinated national 
surveys for prevalence of hypertension. Several regional small surveys 
have been conducted which showed a higher prevalence in urban 
population. 
Many hypertensive patients have a positive family history of 
hypertension. In most instances, the mode of inheritance is complex and 
polygenic. Black men and women have a twofold higher prevalence of 
hypertension (30%) than white men and women (15%). 
According to the data from NHANES, the prevalence of 
hypertension increases sharply with advancing age and high BMI. The 
mean levels of systolic BP and diastolic BP were also found to increase 
as BMI increases. 
 
 
 Various  epidemiological studies have shown that the dietary intake 
of salt correlates with the average BP in a population. An international  
epidemiological study, INTERSALT, showed a significant correlation 
between dietary sodium intake and median systolic BP and diastolic BP. 
Some epidemiological studies have shown that low calcium and 
potassium intake may also lead to hypertension. Blood pressure is 
strongly related to urinary sodium and potassium molar ratio than either 
sodium or potassium alone. 
 Data derived from the Framingham study have shown that 
hypertensive patients have a fourfold increase in cerebrovascular 
accidents , as well as a sixfold increase in congestive heart failure when 
compared to normotensive subjects. 
Higher the levels of systolic BP and diastolic BP, higher the 
disease associated morbidity and mortality which includes atherosclerotic 
cardiovascular disease, stroke, heart failure and renal insufficiency. 
 Cardiovascular and cerebrovascular mortality rates have 
substantially decreased in the past three decades owing to aggressive 
treatment of hypertension. Similar results can be achieved by long term, 
population wide, reduction of salt intake which reduces the prevalence of 
hypertension in the population. 
 
 
NATURAL HISTORY OF HYPERTENSION 
 Perera et al43 in 1950s observed 500 untreated hypertensive 
patients, 150 from before the onset of their hypertension until their death 
and another 350 from the uncomplicated phase until their death. 
 The mean survival of these patients after discovery of their 
hypertension was 20 years. The severity of the casually obtained BP had 
little prognostic value. Some patients with systolic blood pressure above 
200mmHg survived for more than 35 years without any treatment. 
 The disease process included an uncomplicated phase lasting for 
about 15 years followed by a complicated phase. In the complicated 
phase, organ complications, largely arteriolosclerotic and atherosclerotic 
became apparent. 
 Of these complications,74% were cardiac ,42% were renal and 
32% were retinal. More than half the subjects died of heart disease 
(principally congestive cardiac failure), 10% to 15% died of cerebral 
accidents , and about 10% died of renal failure. 
 Malignant hypertension occurred in fewer than 5% of these 
patients. 
 
 
 
RISK FACTORS FOR HYPERTENSION 
 Hypertension is a multisystem disorder with involvement of 
cardiovascular, neuroendocrine and renal systems with a strong genetic 
component. 
Blood pressure is influenced by a number of  environmental , 
genetic and lifestyle factors as shown below: 
NON-MODIFIABLE RISK FACTORS 
1.ROLE OF GENETICS : 
 “Inherited BP” refers to the variations in BP which are determined 
genetically. 20% to 60% of essential hypertension is inherited while the 
remaining is acquired or environmental. 
 Various environmental and lifestyle factors have an influence on 
inherited BP.These include excessive salt intake, weight gain and heavy 
alcohol intake. These factors increase the blood pressure above the 
inherited BP and lead to hypertension. 
 The interactions between genetics and environmental factors 
influence sympathetic overactivity, RAAS, RKKS and endothelial factors 
which inturn influence sodium excretion, vascular reactivity and cardiac 
 
 
contractility. These finally determine cardiac output and peripheral 
vascular resistance and consequently blood pressure. Since many 
intermediary phenotypes are included in this complex mechanism,  many 
genes participate in the development of hypertension. 
 Apart from this, genetic factors also play a role in the behavioural 
pattern of individuals which elevates blood pressure. So, it is difficult to 
assess the proportion of  blood pressure variability due to inheritance and 
this varies in different populations. 
 Mutations in the genes raise or lower blood pressure by altering 
salt and water reabsorption by the nephron through common pathways. 
The genetic mutations responsible for three rare forms of mendelian 
hypertension syndromes – Glucocorticoid remediable aldosteronism 
(GRA), Liddle’s syndrome and apparent mineralocorticoid excess (AME) 
have been identified. 
 Polymorphisms and mutations in the genes for angiotensin 
converting enzyme, angiotensin, B2 adrenergic receptor, adducin, 
angiotensinase C, renin binding proteins, G protein B3 subunit, atrial 
natriuretic factor and the insulin receptor are found to be associated with 
the development of hypertension. 
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along with increased plasma volume results in significant elevation of 
blood pressure. 
 With aging , reductions may occur in brain metabolism, nerve 
conduction velocity, basal metabolic rate, vital capacity and maximum 
breathing capacity which contributes to rise in blood pressure. 
 The compliance of  blood vessels is reduced with aging which 
leads to elevated blood pressure. False elevation of BP can also occur in 
elderly individuals due to thickened peripheral vessels which can be 
identified by Osler maneuver. 
3.SEX : 
 In adult women, blood pressure is lower than in men of comparable 
age. But, the rise in blood pressure is more steep thereafter and around 
middle age, blood pressure is about the same in both men and women.  
MODIFIABLE RISK FACTORS 
1.OBESITY : 
Obesity is one of the modifiable risk factors for the onset of 
hypertension. The Framingham Study showed nearly1mmHg rise of 
Systolic BP for every 1.25kg of weight gain. 
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Cardiac output is directly proportional to the expansion of  
bodymass which is the primary reason for rise in BP. (9)The prevalence of  
hypertension increased equally with increasing BMI, degree of upper 
body obesity and fasting insulin levels. (10) 
Obesity results in insulin resistance and hyperinsulinemia which 
are components of the metabolic syndrome. Such higher insulin levels are 
found to be associated with more hypertension. 
Mechanisms of insulin resistance/hyperinsulinemia induced 
hypertension 
I.Enhanced renal sodium and water absorption : 
  1. Increased blood pressure sensitivity to dietary salt intake. 
 2. Augmentation of the pressure and aldosterone responses to AII 
 (angiotensin II). 
 3. Changes in transmembrane electrolyte transport 
  a. Increased intracellular sodium 
  b. Decreased Na+/K+ - ATPase activity 
  c. Increased intracellular Ca2+ pump activity 
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2.EXCESS SODIUM INTAKE : 
 Excess sodium leads to hypertension by increasing fluid volume 
and preload, thereby increasing cardiac output. Sodium excess also 
affects vascular reactivity and renal function which inturn leads to 
increased blood pressure. (12) (13) 
 The Intersalt study which was conducted in 32 countries projected 
that a 100 mmol/day lower sodium intake over a lifetime would result in 
a 9mmHg smaller rise in systolic BP from 25 to 55 years of age. It 
demonstrated a clear relationship between the salt intake and the level  of  
BP among communities. 
Sodium sensitivity 
 Only about half of the patients with high sodium intake develop 
hypertension which suggests a variable degree of blood pressure 
sensitivity to sodium. 
 The proposed mechanisms for sodium sensitivity are defect in renal 
sodium excretion, increased activity of the sodium hydrogen exchanger, 
increased sympathetic nervous system activity, increased calcium entry 
into vascular smooth muscle & impaired nitric oxide synthesis. (12) (14) (15) 
(16) (17)   Sodium sensitivity increases with advancing age and is found to be 
 
 
more in women than men. (18) (19)Blacks have greater frequency of salt 
sensitivity. 
3.ALCOHOL INTAKE : 
 Excessive alcohol intake is an important cause for hypertension. 
Excess consumption accounts for 5% to 30% of all hypertensive patients. 
Several studies including the Intersalt Study have shown a strong and 
independent positive relationship between alcohol intake and increase in 
blood pressure. 
 Alcohol intake has been found to have a biphasic effect on blood 
pressure. Smaller doses of alcohol has a vasodilatory effect and lowers 
blood pressure, but as alcohol consumption increases blood pressure 
increases leading to hypertension. 
This dose - response characteristics varies from individual to 
individual depending upon various factors such as body surface area, 
gender and race. 
The mechanism for the alcohol induced rise in blood pressure is 
associated with the activation of, or increased responsiveness to the 
sympathetic nervous system. 
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DETERMINANTS OF BLOOD PRESSURE 
 There are five important factors which are responsible for 
maintaining the arterial blood pressure. Following are the five factors: 
1.Cardiac output 
2.Peripheral resistance 
3.Elasticity of the arterial walls 
4.Blood volume 
5.Volume of the vascular space 
1.CARDIAC OUTPUT : 
 When the ventricle contracts , more blood enters the already 
partially filled arteries, and the pressure on the arterial wall rises.(This is 
the pressure during systole). The arterial walls are stretched, the pressure 
rises and then falls as blood leaves the arterial system. Cardiac output 
influences the systolic blood pressure. Increase in cardiac output 
increases systolic pressure, and a decrease reduces the pressure. 
 
 
 
 
2.PERIPHERAL RESISTANCE : 
When resistance to flow is increased,the pressure is high and when 
the resistance is reduced , the pressure falls. The frictional resistance to 
flow of blood depends upon lumen of blood vessels, viscosity of blood 
and velocity of blood flow. 
a.Lumen of blood vessels: 
 The most important factor is the lumen of vessels , especially that 
of arterioles which are the resistance vessels. If the lumen is narrowed (by 
vasoconstriction) the pressure is increased. If the lumen becomes wider 
(by vasodilatation) the pressure is decreased. Peripheral resistance 
influences the diastolic pressure more than the systolic , though both may 
be affected. 
b.Viscosity of blood: 
 When the viscosity of blood is reduced (e.g. in anaemia) resistance 
is low; it is high when the viscosity is increased ( e.g. polycythemia ). 
c.Velocity of blood flow: 
 Increased velocity of blood flow tends to increase the frictional 
resistance. Normally, flow in blood vessels is laminar , but becomes 
turbulent when there is obstruction in a vessel or the surface is roughened 
 
 
(e.g. atherosclerosis). Turbulent flow sets up eddy currents and the 
resistance to flow is much increased. 
However, the moment to moment adjustments of resistance is 
brought about by alterations in the lumen size by the vasomotor tone. 
3. ELASTICITY OF THE ARTERIAL WALLS : 
 The large arteries are elastic and distensible and it is the elasticity 
of the arterial walls that is responsible for the origin and maintenance of 
the diastolic pressure. 
 If the arteries were rigid inelastic tubes, the pressure on the walls 
will rise steeply when blood enters the vessel during systole, and during 
diastole when no blood enters, the pressure will drop to zero. 
 Because the arteries are elastic , they stretch when blood enters 
during systole and prevent a large rise in systolic pressure. During 
diastole, when the entry of blood ceases, the arterial walls recoil, and this 
is responsible for the diastolic pressure.The recoil also acts as a secondary 
pump to push blood along the vessels during diastole. 
 The elastic recoiling of the arterial walls and the peripheral 
resistance in the arterioles are responsible for converting the intermittent 
flow of blood in the arteries to a continuous flow. 
 
 
4.BLOOD VOLUME : 
 Increase in blood volume causes the arterial system to be overfilled 
and raises both systolic and diastolic blood pressures. A reduction in 
blood volume reduces the blood pressure. 
5.VOLUME OF THE VASCULAR SPACE : 
 If the volume of the vascular space is increased by dilatation of the 
arterioles and capillaries, the blood pressure is reduced. If the vascular 
space is decreased , blood pressure is increased. 
 The blood volume and vascular space do not change much under 
normal circumstances. The elasticity also does not change , except very 
gradually with age over a long period of time or as a result of disease. 
Hence, the day to day regulation of arterial blood pressure is by 
changes in the cardiac output and peripheral resistance. 
The amount of blood entering the arteries is determined by the 
cardiac output. Blood leaving the arteries is determined by the peripheral 
resistance. Hence, if cardiac output or peripheral resistance or both are 
increased, blood pressure rises. If cardiac output or peripheral resistance 
or both are decreased blood pressure falls. 
 
 
 
PHYSIOLOGY OF BLOOD PRESSURE 
HOMEOSTASIS 
The basic equation in the physiology of blood pressure is 
Blood pressure = cardiac output × peripheral resistance 
Cardiac output = Heart rate × stroke volume 
 Blood volume varies directly with total body sodium content 
because sodium is the predominant extracellular solute that retains water 
within the extracellular space. 
ROLE OF KIDNEYS 
 The primary function of the kidneys is to regulate sodium and 
water excretion and consequently , they also play a dominant role in the 
long term control of BP.  
The most important and fundamental mechanism in determining 
the long term control of blood pressure is the renal fluid - volume 
feedback system. Through this feedback system, the kidneys regulate 
arterial pressure by altering renal excretion of sodium and water, thereby 
controlling circulatory volume and cardiac output. Changes in BP, in turn  
directly influence the renal excretion of sodium and water, thereby 
 
 
providing a significant feedback system for controlling extracellular fluid 
volume, cardiac output, and BP. 
  Two important renal mechanisms play a significant role in the long 
term control of blood pressure. 
 In the first mechanism, extracellular fluid volume is regulated by 
coupling the magnitude of urinary salt and water excretion and the related 
changes in blood volume and cardiac output , to changes in renal 
perfusion pressure.This phenomenon is called pressure natriuresis which 
is explained by Guyton and his co-workers. (20) (21) 
In the second mechanism , Renin-Angiotensin-Aldosterone System 
(RAAS) is employed. It has a direct control over peripheral vascular 
resistance and reabsorption of sodium and water in renal tubules. RAAS 
is the long term regulator of  blood pressure homeostasis . (22) (23)  
I . PRESSURE  NATRIURESIS: 
 Pressure natriuresis is the central component of the negative 
feedback system which is responsible for the long term control of blood 
pressure. Pressure natriuresis is defined as an increase in sodium and 
water excretion by kidneys that occurs when arterial pressure rises.    
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1.RIHP: 
Elevated renal perfusion pressure significantly increases RIHP, 
even in the absence of increased GFR and renal blood flow. (24) Pressure 
natriuresis can be attenuated but cannot be abolished by preventing the 
rise in RIHP in reponse to perfusion pressure. (25) 
The exact mechanism by which RIHP affects tubular reabsorption 
is not known. It appears to be associated with changes in permeability of 
tight junctions in the proximal tubules to sodium, redistribution of apical 
sodium transporters and release of prostaglandin E2.  
2.NITRIC OXIDE : 
Nitric oxide plays a significant role in renal hemodynamics and 
hence influences BP. (26)  Renal medullary blood flow has an important 
role in maintaining blood pressure homeostasis. Nitric oxide is tonically 
active in the medullary circulation and regulates medullary renal vascular 
resistance, natriuresis and diuresis. (27) 
Reduction in nitric oxide production enhances pressure natriuresis 
response followed by reduction in medullary blood flow, RIHP and 
sodium excretion without corresponding changes in total or cortical  renal 
blood flow or GFR. (28)  
 
 
3. KININS :  
 Kinins produce pressure natriuresis by inhibiting sodium 
reabsorption in the distal part of the nephron or by producing changes in 
the deep nephron reabsorption. 
 Kinins affect sodium reabsorption in three ways : i. Direct effect on 
the transport of sodium along the nephron, ii. A vasodilator effect, iii. 
Changes in the osmotic gradient of renal medulla. 
4. METABOLITES OF ARACHIDONIC ACID : 
 Arachidonic acid is an important component of cell membrane. It is 
metabolised into hydroxyeicosatetraenoic acid (20-HETE) and 
epoxyeicosatrienoic acids (EETs) by cytochrome P450 enzymes. 
 Both EETs and 20-HETEs have a significant impact on renal 
vascular tone and sodium excretion and hence regulates pressure 
natriuresis. 
 These metabolites inhibit Na+/K+ - ATPase activity and promotes 
internalisation of NHE3 proteins at the brush border of proximal tubule   
thereby inhibiting proximal tubule renal transport and increasing urinary 
sodium excretion. 
 
 
 
II .
FIG
 
jux
i.d
of 
iii.
 
ang
fro
 RENIN A
 6.Schem
Renin
taglomeru
ecreased s
sodium ch
increased
Renin
iotensino
m the live
NGIOTE
atic diag
 is a glyco
lar cells 
ignal from
loride de
 renal nerv
 is a prote
gen , whi
r and is c
NSIN AL
ram of ren
protein h
of kidney
 macula 
livered, ii
e activity
olytic enz
ch is a pla
onverted 
DOSTER
in - angio
ormone w
 .The sign
densa wh
.decreased
. 
yme whic
sma prote
to Angiot
ONE SY
tensin - a
hich is se
als for ren
ich detect
 renal art
h acts on
in. Angio
ensin I wi
STEM :
ldosteron
creted by
in release
s changes
eriolar pr
 its substr
tensinoge
th the help
e system. 
 
 include 
 in the loa
essure and
ate 
n is secre
 of renin
d 
 
ted 
. 
 
 
 During the passage of Angiotensin I through lungs , it is converted 
into Angiotensin II by a converting enzyme which is present on the 
surface endothelial cells of pulmonary vessels. Angiotensin II is rapidly 
inactivated by enzymes called angiotensinases. 
 Angiotensin II is the biologically active product of the 
juxtaglomerular Renin – Angiotensin system and is a vasoconstrictor and 
stimulates aldosterone. 
ACTIONS OF ANGIOTENSIN II  
1.Aldosterone cortex : 
 Angiotensin II stimulates the secretion of aldosterone from adrenal 
cortex. When there is a reduction of ECF volume or blood volume or 
Nacl concentration, aldosterone secretion is increased through the Renin-
Angiotensin mechanism. Aldosterone promotes sodium reabsorption in 
the renal tubules, with chloride and water following sodium , and thus 
restores fluid and salt balance. 
2. Cardiovascular system : 
 The most prominent action of Angiotensin II is vasoconstriction 
produced directly as well as by enhancing adrenaline or nor-adrenaline 
release from adrenal medulla and by increasing central sympathetic flow. 
 
 
Angiotensin II also increases force of myocardial contraction by 
promoting calcium reflux and influences cardiac output. 
3.Renal system : 
 In addition to exerting indirect effect on kidney through 
aldosterone, A- II promotes Na+/K+ exchange in proximal tubules which 
leads to sodium, chloride and bicarbonate reabsorption. Further, it 
reduces renal blood flow and produces intrarenal hemodynamic effects 
which normally results in sodium and water retention. 
4.CNS : 
 Angiotensin II induces drinking behaviour and ADH release which 
leads to plasma volume expansion. It also increases central sympathetic 
outflow contributing to the pressor response. 
5.Peripheral nervous system : 
 It releases adrenaline from adrenal medulla, stimulates autonomic 
ganglia, and increases the output of nor- adrenaline from adrenergic nerve 
endings. 
 Thus, Renin- Angiotensin-Aldosterone system plays a major role in 
the blood pressure homeostasis. 
 
 
 
PATHOPHYSIOLOGY OF HYPERTENSION 
ALTERED RENAL PHYSIOLOGY: 
 Essential hypertension is primarily due to an abnormal kidney 
which leads to impaired excretion of sodium. (29)Various hypotheses have 
been proposed to explain that , abnormal sodium retention by the kidneys 
is the main initiating event for hypertension. 
1.GUYTON’S HYPOTHESIS : 
 Guyton’s hypothesis states that derangements in the renal fluid – 
volume pressure control mechanism forms the basis of virtually all 
hypertensive states. 
 In every hypertensive state , there exists an underlying 
abnormality in the intrinsic natriuretic capacity of the kidney so that the 
daily salt intake cannot be excreted at a normal BP, and the development 
of hypertension is necessary to induce a pressure natriuresis that allows 
the kidney to excrete the daily salt intake. Normal sodium balance and 
ECF volume are maintained but at the expense of systemic hypertension. 
Depending upon the etiology of hypertension, the underlying cause 
for the abnormality in the natriuretic capacity of the kidney varies. In 
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To date , each of the genetic causes of hypertension that have been 
elucidated has been found to be related to an abnormality of renal sodium 
handling. For example, Liddle’s syndrome occurs due to an abnormality 
in sodium channels in the distal nephron which leads to enhanced distal 
tubular sodium reabsorption. 
Guyton’s hypothesis states that this impaired natriuretic capacity of 
the kidney leads to sodium and water retention initially which in turn   
leads to ECF volume expansion and increased cardiac output with 
hypertension. But, this phase of volume expansion and high cardiac 
output is short lived. 
In this high cardiac output state, autoregulatory vasoconstriction of 
each vascular bed matches the blood flow to the metabolic requirements 
of the tissues.This phenomenon of circulatory autoregulation results in an 
increase in the systemic vascular resistance (SVR). Therefore, 
hypertension that was initially caused by high cardiac output becomes 
high SVR hypertension. 
The development of hypertension represents a protective 
mechanism, because it induces the kidney to undergo a pressure 
natriuresis and diuresis , thereby restoring normal salt balance and 
returning ECF volume to normal.   
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4. RENIN –ANGIOTENSIN – ALDOSTERONE SYSTEM : 
 Renin plays a significant role in the pathogenesis of hypertension. 
(33) In essential hypertension, normally, low levels of renin are expected. 
But , majority of the patients with essential hypertension show 
inappropriately normal or even elevated plasma renin levels. About 20% 
are found to have high renin levels, and about 30% have low renin values, 
with the remaining half distributed between these two extremes. 
 Three mechanisms have been offered for such variations in renin 
levels. The mechanisms are described below : 
A. Nephron heterogeneity in essential hypertension : (34) 
 Nephron heterogeneity with unsuppressible renin secretion is 
proposed as the cause for essential hypertension. 
 Within the kidneys, there exists a functional and structural basis for 
the abnormal renin secretion and impaired sodium excretion that are 
characteristics of hypertensive states. 
 Hypothesis - there is nephron heterogeneity in essential hypertension : 
i. There are ischemic nephrons with impaired sodium excretion 
intermingled with adapting hyperfiltering hypernatriuretic 
nephrons. 
 
 
ii. Renin secretion is high from ischemic nephrons and low from 
hyperfiltering nephrons. 
iii. The inappropriate circulating renin-angiotensin level impairs 
sodium excretion because: 
a. In the adapting hypernatriuretic nephrons 
  - It increases tubular sodium reabsorption. 
- It enhances tubuloglomerular feedback mediated afferent 
constriction. 
  b.  As the circulating renin level is diluted by non- participation of 
adapting nephrons, it becomes inadequate to support efferent tone in 
hypoperfused nephrons. 
iv.  A loss of nephron number with age and from ischemia further 
impairs sodium excretion.  
B. Theory of  non – modulation  
  About half of the hypertensive patients have normal and high renin 
levels. Williams and Hollenberg proposed a theory of non–modulation (35) 
which states that defective feed – back regulation of the renin – 
angiotensin system within the kidneys and the adrenal glands is 
responsible for this normal and high renin levels. 
 
 
In normal individuals , the responsiveness of the target tissues to 
angiotensin II is modulated with their level of dietary sodium intake. 
Sodium restriction enhances adrenal secretion of aldosterone and reduces 
vascular response, leading to sodium loading which inturn suppresses 
adrenal response and enhances vascular response , particularly within the 
renal circulation.  
Sodium restriction reduces renal blood flow facilitating sodium 
conservation while sodium loading increases renal blood flow promoting 
sodium excretion. All these effects are mediated by angiotensin II levels 
which increases with sodium restriction and decreases with sodium 
loading. 
Non – modulation is characterized by abnormal renal and adrenal 
responses to Angiotensin II and dietary salt loads. (36) This is due to an 
abnormally regulated and fixed level of angiotensin II , which does not 
increase adrenal secretion of aldosterone in response to sodium restriction 
and in the renal circulation , does not increase renal blood flow in 
response to sodium loading. 
This hypothesis is supported by the fact that suppression of 
angiotensin II by ACE inhibitors in such non – modulators , corrects both 
the adrenal and renal defects. 
 
 
c. Low renin essential hypertension 
 Low renin levels are found in about 40% of patients with essential 
hypertension . Volume expansion with or without mineralocorticoid 
excess has been proposed as the possible mechanism for low renin 
hypertension. 
 Fishar et al focussed on adrenal and pressure responsiveness to 
angiotensin II which depends on the dietary salt intake in patients with 
normal renin hypertension , low renin hypertension and normal controls. 
 Comparison of patients with normal renin hypertension and non-
modulating essential hypertension with normal plasma renin activity 
showed some similarities which include  
i. Salt sensitivity of the blood pressure 
ii. Blunted plasma aldosterone responses to angiotensin II and upright 
posture after dietary sodium restriction for 5 days. 
iii. Relatively low basal plasma aldosterone levels. 
 When normal controls and modulating hypertensive subjects are 
compared , there were significant differences between them which 
disappeared when dietary salt intake was increased. 
 
 
 
 With high sodium intake , plasma angiotensin II activity is 
suppressed which leads to resensitisation of angiotensin II receptors and  
improved responsiveness of target tissues to angiotensin II. 
 With sodium restriction , there is blunted responsiveness to 
angiotensin II owing to continuing generation of angiotensin II and 
angiotensin receptor downregulation in target tissues. 
 An impaired hydroxy steroid dehydrogenase type 2 ( HSD II B2 ) 
activity plays a significant role in the pathogenesis of essential 
hypertension in some patients. 
 Apparent mineralocorticoid excess ( AME ) is a rare monogenic 
juvenile hypertensive syndrome which occurs due to mutations in the 
HSD II B2 gene. In AME , altered HSD enzyme activity causes excessive 
stimulation of the mineralocorticoid receptor by cortisol which leads to  
hypokalemia, sodium retention and salt dependent hypertension. (37) (38) 
 The prevalence of mutations in HSD II B2 in general population of 
patients with essential hypertension presently unknown. It is important to 
seek the diagnosis of AME by genetic and clinical studies because 
specific therapy such as spironolactone is available for this disease which  
causes ready remission . 
 
 
TWO FORMS OF VASOCONSTRICTION IN PRIMARY 
HYPERTENSION 
 Two forms of vasoconstriction , one mediated by sodium – volume 
forces and the other mediated by renin – angiotensin system are essential 
to maintain normal BP homeostasis. When these mechanisms are 
impaired , hypertension occurs. These spectral patterns of 
vasoconstriction seen in seen in extreme forms of hypertension also 
operate in primary hypertension. 
 Laragh and his co-workers attached a great significance to various 
plasma renin activity levels ( PRA) levels found in patients with essential 
hypertension. According to their view , based on the renin levels , the 
relative contribution of vasoconstriction and body fluid expansion to the 
pathogenesis of hypertension can be identified. 
 According to the “ bipolar vasoconstriction – volume analysis”, 
arteriolar vasoconstriction by angiotensin II is predominantly responsible 
for the hypertension in patients with high renin whereas volume 
expansion is predominantly responsible in those with low renin. Both 
lead to increased peripheral resistance which is the common characteristic 
of all hypertension. 
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5. SHEPHERD’S HYPOTHESIS : 
 In normal individuals , when there is an increase in the blood 
pressure or central venous pressure , the baroreceptors are activated and 
they reduce heart rate and lower blood pressure, respectively, by vagal 
stimulation and sympathetic inhibition. 
 When there is sustained hypertension, resetting of the baroreceptor 
reflexes occur due to structural and functional changes so that an increase 
in blood pressure evokes less reduction in heart rate. (40) 
 Shepherd’s hypothesis states that the decreased inhibition of the 
vasomotor center which results from resetting of the arterial 
baroreceptors may be responsible for increased sympathetic outflow and 
thereby in the perpetuation of hypertension. (41)  
6. SALT  DEPENDENT  HYPERTENSION :  
 It has been proposed that hypertension has two phases. An early 
phase in which the elevations in blood pressure are mainly episodic and 
are mediated by a hyperactive sympathetic nervous system or renin-
angiotensin system. The second phase is characterised by persistently 
elevated BP which is primarily mediated by an impaired ability of the 
kidney to excrete sodium chloride salt. 
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The acute norepinehrine or angiotensin II mediated elevation in 
blood pressure is transmitted to the peritubular capillaries of the kidney in 
association with a reduction in blood flow, secondary to the 
vasoconstrictive properties of these substances. Capillary damage and 
tubulointerstitial injury with fibrosis results.  
The local ischemia stimulates ( adenosine , ang II , renal 
sympathetic nerve activity ) or inhibits ( nitric oxide , prostaglandins , 
dopamine ) vasoactive mediators , resulting in NaCl reabsorption due to 
enhanced tubuloglomerular feedback.The capillary damage and increase 
in renal vascular resistance also blunts pressure natriuresis mechanism. 
The consequences of both enhanced tubuloglomerular feedback 
and impaired pressure natriuresis is an acquired functional defect in 
sodium chloride excretion . This results in the resetting of the pressure – 
natriuresis curve to a higher pressure in order to restore sodium balance  
back to normal. (42) 
This is proposed as the major mechanism for the development of 
salt dependent hypertension. Thus , essential hypertension may be a type 
of acquired tubulointerstitial renal disease.  
 
 
 
In conclusion , this hypothesis links early, episodic, salt 
independent hypertension with the later development of a persistent salt 
dependent hypertension with a new concept that it is mediated by 
acquired tubulointerstitial and peritubular capillary injury. 
The strength of this hypothesis is that it unites many prior 
hypotheses into one pathway ; including that of Guyton et al on impaired 
pressure natriuresis (20), of Brenner on reduced nephron number (39), of 
Sealey and Laragh on activation of the renin angiotensin II system (34), 
of Cowley et al on the role of medullary ischemia (26), of Kurokawa on 
enhanced tubuloglomerular feedback (43), of Julius on the role of the 
sympathetic nervous system in early hypertension (44). 
In addition , this hypothesis potentially provides answers to many 
questions not easily addressed by other individual hypothesis. 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 Many epidemiological studies have shown a strong relationship 
between dietary salt intake and hypertension. Few studies regarding the 
association of salt intake and blood pressure are  mentioned here. 
1.Carherine E Huggins et al assessed 24 hour urinary sodium and 
potassium excretion and examined the relationship to blood pressure 
within a population of middle aged and older Australian adults. In the 
five hundred and eighty seven participants with blood pressure 
measurements , urinary sodium and the sodium to potassium ratio were 
both associated with systolic blood pressure even after adjustment for 
age, sex and BMI.The study demonstrated that sodium intake is positively 
associated with blood pressure. (45) 
2. Rosa M.Ortega et al studied about the sodium intake of a 
representative sample in the Spanish young and middle aged population. 
Sodium intake was measured by 24 hour urinary sodium excretion. In this 
study, urinary sodium excretion significantly correlated with systolic and 
diastolic blood pressure .About 88% of the subjects in the study group 
had salt intakes above 5g/day. Male subjects and participants with higher 
BMI were found to be associated with high urinary sodium excretion . (46) 
 
 
3.B.M.Y CHEUNG et al studied seventy Chinese patients with untreated 
hypertension and forty seven normotensive controls. For each subject , 
blood pressure and 24 hour urinary sodium & potassium excretion were 
measured. 22 hypertensive patients underwent ambulatory blood pressure 
monitoring. In hypertensive patients, the diastolic BP directly correlated 
with 24 hour urinary Na excretion while in normotensive controls , it did 
not correlate with 24 hour urinary sodium excretion. Even patients who 
underwent ambulatory blood pressure monitoring showed a significant 
correlation between diastolic BP and sodium excretion. Systolic blood 
pressure did not correlate with sodium excretion , although it increased 
with advancing age of the patient. (47) 
4.RA JAN et al studied the relationship of 24 hour urinary Na+ and K+ 
excretion, Na+/K+ molar ratio and body mass index with blood pressure in 
hypertensive patients and normotensive controls in Kashmir. 24 hour 
urinary Na+ excretion, Na+/K+ molar ratio and body mass index were 
significantly increased in hypertensive people when compared to normal 
individuals. But , 24 hour urinary K+ excretion was low in hypertensive 
patients. Thus , Na+ and K+ excretion , Na+/K+ molar ratio and BMI were 
found to have a direct role in the etiology or perpetuation of hypertension 
in Kashmir, which was attributed to high intake of salt tea in this 
population. (4) 
 
 
5.KUO – LIONG CHIEN et al reported about the role of 24 hour 
urinary sodium excretion in the development of hypertension among 
ethnic Chinese community. In this prospective cohort study from Chinese 
community, a significant J-shaped relationship was observed between 24 
hour urinary sodium excretion and the risk of hypertension. Subjects in 
the highest quartile of urinary Na+ excretion and higher baseline BP had 
twofold increased risk of hypertension when compared to those in the 
lowest quartile of urinary Na+ excretion and lower blood pressure. High 
urinary Na+ excretion was associated with significant risk of hypertension 
in ethnic Chinese population. (48) 
6.INTERSALT (3) , an international epidemiological study examined the 
relation between dietary sodium intake ( based on 24 hour urinary sodium 
excretion ) and BP in more than ten thousand individuals, aged between 
twenty and fifty nine years, from fifty two countries around the world. 
Sodium excretion correlated strongly and positively with blood pressure 
while potassium excretion correlated negatively with blood pressure in 
individual subjects, even after controlling for confounding variables. 
Na+/K+ molar ratio also correlated positively with blood pressure. Age, 
BMI and high alcohol intake had strong influence on blood pressure in 
individual subjects . Among 52 countries in the study, four countries 
recorded lower blood pressure owing to low salt intake in these regions. 
 
 
  7.SONJA L. CONNOR et al studied the relationship of blood pressure 
with age , body weight and multiple dietary factors  among the members 
of more than two hundred randomly selected families. Age , bodyweight 
and heart rate were independently and positively correlated with blood 
pressure. A strong familial component was identified for urinary Na+ and 
K+ excretion and for systolic BP. In females, urinary sodium and 
potassium excretions correlated positively with diastolic BP. But , this 
relationship did not persist after controlling for confounding variables 
such as age and body weight. In males, intake of dietary factors such as 
potassium, calcium and phosphorous correlated positively with systolic 
BP even after controlling for confounding variables.This is in contrast to 
other studies which showed a negative correlation between potassium 
intake and blood pressure. (49) 
8.SUSAN  HEDAYATTI et al studied the correlation between urinary 
sodium & potassium molar ratio and blood pressure in more than 3000 
participants. 56% of the participants were women and 52% were African 
Americans. Urinary Na+/K+ molar ratio correlated positively with both 
systolic and diastolic blood pressure even after adjusting for serum 
cholesterol, smoking, diabetes mellitus, BMI and GFR . Both systolic and 
diastolic BP were significantly elevated in African Americans when 
compared to non – African Americans. (50) 
 
 
 
 
AIMS AND OBJECTIVES 
1.To study the association between 24 hours urinary sodium & potassium                         
excretion and blood pressure in patients with essential hypertension. 
2.Our study was based on GUYTON’s hypothesis which states that 
individuals with impaired capacity to excrete sodium require greater 
increase in arterial pressure to maintain sodium balance. 
3.The anticipated outcome in our study was that individuals with high 
urinary sodium excretion and low urinary potassium excretion were more 
likely to develop hypertension.  
 
 
 
 
 
 
 
MATERIALS AND METHODS 
SOURCE OF DATA : 
 The study was conducted in Government RajajiHospital,Madurai 
among patients attending outpatient clinic in general medicine.40 patients 
as per criteria of JNC VI report and equal number of age and sex matched 
controls were taken up for study. 
DESIGN OF STUDY: 
 Our study was a randomised prospective study comparing two 
groups – Hypertensives and Normotensives. 
PERIOD OF STUDY: 
 The  study was conducted for a period of eight  months from April 
2012-November 2012. 
ETHICAL APPROVAL: 
 Obtained from institutional ethical committee headed by 
DEAN,Government Rajaji hospital ,Madurai. 
 
 
CONSENT :An informed written consent was obtained from all the 
subjects included in the study. 
 
STUDY GROUP: 
INCLUSION CRITERIA: 
1.Age between 18 and 75 years. 
2.Hypertension as per JNC VI report-BP – 140/90 mmHg least at three 
different occasions after refraining from anti-hypertensives and diuretics 
for atleast three weeks before the study. 
3.Refraining from eating,smoking or indulging in any stressful activity 30 
minutes before recordings. 
EXCLUSION CRITERIA: 
1.Patients with secondary hypertension. 
2.Patients on NSAIDs, anti-hypertensives,diuretics. 
3.Patients with congestive cardiac failure. 
4.Patients with malignant hypertension. 
5.Females on oral contraceptive medications. 
 
 
CONTROL GROUP: 
1.Same age and sex. 
2.BP lower than 140/90 mmHg. 
 
METHODOLOGY: 
 A detailed medical history was obtained from all the subjects. 
Family history of hypertension,Diabetesmellitus,cardiovascular disease 
and renal disease were sought. Duration of hypertension ,levels of 
elevated blood pressure,results and side effects of anti-hypertensive 
therapy were recorded. History of all the prescribed and over the counter 
medications,smoking,alcoholuse,weight gain and symptoms suggestive of 
secondary hypertension were obtained. 
 A complete physical examination was conducted for all the 
subjects which included pulse and BPmeasurements,examination of 
extremities for edema,examination of neck for distended 
veins,thyromegaly,examination of cardiovascular,respiratory,abdominal 
and central nervous systems,optic fundoscopic examination for any 
hypertensive changes. Height and weight were measured and Body mass 
Index was calculated as weight in kg/height in m2. 
 
 
 Blood pressure was measured on three different occasions with 
same standard mercury sphygmomanometer in both supine and standing 
positions. The average of three readings was used in data analysis. 
 
 The following investigations were done in all the subjects: 
1.Completehemogram 
2.Urine analysis 
3.Serum – sugar,urea,creatinine,calcium,phosphorus,uric acid and 
cholesterol 
4.Serum – sodium and potassium 
5.24 hours urinary sodium and potassium excretion.Na+/K+ molar ratio 
was calculated. 
6.USG abdomen and pelvis 
7.ChestXray 
8.Electrocardiogram and Echocardiography 
9.Thyroid profile 
 
 
 
24 hour urine collection was done in our study group to measure 
urinary sodium and potassium excretion. All the participants were 
instructed to collect urine for 24 hours and not to alter their dietary 
pattern during collection so that the urinary sodium and potassium 
excretion amount was a direct measure of sodium and potassium intake of 
the individuals. 
 
STASTICAL ANALYSIS: 
 Statistical analysis was performed using statistical software 
Medcalc version 12.3 for Windows. P value <0.05 was considered 
significant. Baseline characteristics between cases and controls were 
compared using student t test for quantitative variables and chi square test 
for qualitative variables. Relationship between different variables were 
analysed by partial correlation after controlling for potential confounders 
(age,sex&BMI). The different trends in sodium and potassium excretion 
depending upon age group, BMI and severity of hypertension were 
analysed using ANOVA. 
 
 
 
RESULTS AND OBSERVATIONS 
TABLE 1 
Distribution of age among study group 
 
     GROUP 
 
 NO 
                   AGE  
    P VALUE     MEAN       S.D 
     CASES  40      49.73  10.698  
      0.3328      CONTROLS  40      47.43  10.406 
 
 In our study,the age of normotensive group ranged from 20-65 
years whereas in the hypertensive group it ranged from 25-68 years. 
 The mean age in the normotensive  group was 47.43 with standard 
deviation of 10.406. 
 The mean age in the hypertensive group was 49.73 with standard 
deviation of 10.698. 
 P value was 0.3328 which was not significant. 
 So, there was no significant difference in the distribution of age 
among hypertensives and normotensives. 
 
 
TABLE 2 
Distribution of study population in relation to gender 
 
          SEX 
   HYPERTENSIVES   NORMOTENSIVES 
  NO PERCENTAGE   NO PERCENTAGE
        MALES   22         55   20         50 
        FEMALES   18         45   20         50 
       TOTAL   40        100   40        100 
 
 In our study population, 42 were males and 38 were females.52.5% 
were males and 47.5% were females. 
 In  hypertensive group, there were 22 males and 18 females.55% 
were males and 45% were females. 
 In the normotensive group, there were 20 males and 20 females.   
50% were males and 50% were females. 
 P value was 0.8228 which was not significant.This suggests that 
there was no significant difference in the distribution of gender among 
study population. 
 In the study population 52.38% of males were hypertensives while 
in females 47.37% were hypertensives. 
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TABLE 3 
BMI distributions in the study population 
 
    BMI 
   HYPERTENSIVES   NORMOTENSIVES  
 P value   No Percentage   No Percentage 
   < 25   24          60%   31        77.5%  
 
0.096 
   ≥ 25   16          40%    9        22.5% 
  Total   40         100   40        100 
  MEAN             24.3020             23.479 
     S.D               2.445             1.894 
 
The average BMI in the hypertensive group is 24.3020 ± 2.445 
whereas the average BMI in the normotensive group is23.479 ± 
1.8937.There was no significant difference in the BMI distributions 
among cases and controls as the P value is 0.096 which is not significant.   
 In our study population, 25 people had high BMI and 55 had 
normal BMI.31.2% had high BMI while 68.7% had normal BMI.Of the 
40 people in the hypertensive group,16 had high BMI and 24 had normal 
BMI whereas in the normotensive group 9 had high BMI and 31 had 
normal BMI. 
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40% of  hypertensives had high BMI while in normotensives 
22.5% had high BMI. 
64% of people with high BMI were hypertensives while 43.64% of 
people with normal BMI were hypertensives. 
TABLE 4 
Comparison of serum cholesterol between hypertensives and 
normotensives 
 Hypertensives Normotensives  P value   Remarks 
Mean    S.D Mean   S.D 
 
Serum 
cholesterol 
 
193 
 
 
14.768 
 
183.15
 
 13.275 
 
0.0024 
 
significant 
 
The average cholesterol in the hypertensive group was 193 ± 
14.768 whereas the average cholesterol in the normotensive group was 
183.15 ± 13.275. 
P value was 0.0024 which was statistically significant.This 
suggests that there was significant difference in the cholesterol levels 
among cases and controls. 
 
 
TABLE 5 
Comparison of serum electrolytes between hypertensives and 
normotensives 
 Hypertensives Normotensives  
   p value 
 
Remarks Mean S.D Mean S.D 
Serum Na 140.43 4.031 138.28 2.837     0.007 Significant 
Serum  K 3.90 0.387   3.79 0.287     0.127 Not significant 
 
 The average serum sodium in the hypertensive group was 140.43 ± 
4.031 whereas  the average serum sodium in the normotensive group was 
138.28 ± 2.837.P value was 0.007 which was  statistically significant. 
 The average serum potassium in the hypertensive group was 3.90 ± 
0.387 while in the normotensive group  it was 3.79 ± 0.287.P value was 
0.126 which was not significant statistically. 
 There was significant difference in serum sodium  levels among 
hypertensives and normotensives. Serum sodium  levels were higher in 
hypertensives when compared to normotensives.There was no significant 
difference in potassium levels between the two groups. 
 
 
 
TABLE 6 
Comparison of serum calcium and phosphorus betweenhypertensives and 
normotensives 
 Hypertensives Normotensives  
P value 
 
Remarks Mean S.D Mean S.D 
Serum 
calcium 
 
9.590 
 
0.534 
 
9.440 
 
0.605 
 
  0.2433 
 
Not significant 
Serum 
phosphorus 
 
3.755 
 
0.295 
 
3.680 
 
0.272 
 
  0.2409 
 
Not significant 
 
 The mean serum calcium in the hypertensive group was 9.590 with 
a standard deviation of 0.534 while the mean serum calcium in the 
normotensive group was 9.440 with a standard deviation of 0.605 .P 
value was 0.2433 which was not significant. 
 The mean serum phosphorus in the hypertensive group was 3.755 
with a standard deviation of 0.295 while  the mean serum phosphorus in 
the normotensive group was 3.680 with a standard deviation of 0.272.     
P value was 0.2409 which was not significant.There was no significant 
difference in serum Ca2+ and phosphorus levels among hypertensives and 
normotensives. 
 
 
TABLE 7 
Comparison of glycemic levels between hypertensives and normotensives  
   Group  No Mean    S.D  P value    Remarks 
Blood   
Sugar 
Cases  40 103.90  9.9403  
 0.4371 
 
Not significant Controls  40 102.45  6.2468 
 
 The mean blood sugar  was 103.90  ±  9.9403 among cases and 
102.45 ± 6.2468 in controls.P value was 0.4371 which indicates there was 
no significant difference  in the glycemic status of both the groups. 
TABLE 8 
Comparison of serum uric acid between hypertensives and normotensives 
 Group  No  Mean    S.D P value     Remarks 
Serum 
Uric acid 
Cases  40  5.958  0.5514  
0.2001 
 
Not significant Controls  40  5.775  0.7027 
 
 The mean serum uric acid was 5.958 ± 0.5514 in the hypertensive 
group and 5.775 ± 0.7027 in the normotensive group.P value was 0.2001 
which was not significant. 
 
 
TABLE 9 
Distribution of study population in relation to renal parameters 
 Group No Mean S.D P value Remarks 
Serum 
Urea 
Cases  40  36.20  6.603  
 0.2769 
Not 
significant Controls  40  34.48  7.463 
Serum 
Creatinine 
Cases  40   0.98  0.281  
 0.2920 
Not 
significant Controls  40   0.92  0.267 
 
 The mean serum urea in the hypertensive group was 36.20 with a 
standard deviation of 6.603while the mean serum urea in the 
normotensive group was 34.48 with a standard deviation of 7.463.P value 
was 0.2769 which was not significant. 
 The mean serum creatinine in the hypertensive group was 0.98 
with a standard deviation of 0.281 while the mean serum creatinine in the 
normotensive group was 0.92 with a standard deviation of 0.267 . P value 
was 0.2920  which was not significant. 
 There was no significant difference in the serum urea and 
creatinine levels between the hypertensive group and normotensive 
group. 
 
 
TABLE 10 
Distribution of Blood pressure among cases and controls 
Blood pressure Group   No  Mean    S.D  P value Remarks 
Systolic BP Cases  40 166.55 10.564  
<0.0001 
Highly 
significantControls  40 115.75  5.995 
Diastolic BP Cases  40  98.20  4.525  
<0.0001 
Highly 
significantControls  40  77.70  4.784 
 
 The mean systolic blood pressure among cases was 166.55 with a 
standard deviation of 10.564 while the mean systolic blood pressure 
among controls was 115.75 with a standard deviation of 5.995. P value 
was < 0.0001 which was highly significant. 
 The mean diastolic blood pressure was 98.20 among cases with a 
standard deviation of 4.525 while the mean diastolic blood pressure was 
77.70 in the control group with a standard deviation of 4.784. P value was 
<0.0001 which was highly significant. 
 Both the systolic and diastolic blood pressures were significantly 
high among cases when compared to controls. 
 
 
 
TABLE 11 
Distribution of 24 hours urinary sodium and potassium excretion among 
hypertensives and normotensives 
Electrolytes Group      Mean       S.D    P value 
Urinary Na+ 
excretion 
Cases    174.550     14.551   <0.0001 
Controls    154.425     17.279 
Urinary K+ 
excretion 
Cases     52.850      7.343     0.2242 
Controls     54.925      7.797 
Na+K+ molar 
ratio 
Cases     3.36:1     <0.0001 
Controls     2.87:1 
 
 The mean 24 hour urinary sodium excretion in the hypertensive 
group was 174.550 ± 14.551 while the mean 24 hour urinary sodium 
excretion in the normotensive group was 154.425 ± 17.279. P value was 
<0.0001 which was highly significant. 
 The mean 24 hour urinary potassium excretion in the hypertensive 
group was 52.85 ± 7.343 while the mean 24 hour urinary potassium 
excretion in the normotensive group was 54.93 ± 7.797.P value was 
0.2242 which was not significant. 
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TABLE 12 
Relationship of 24 hours urinary sodium and potassium excretion with 
severity of systolic hypertension 
 
Group 
      Severity of systolic hypertension  
  P value           Mild  Moderate toSevere 
No Mean±S.D No Mean±S.D 
Urinary sodium 
excretion 
11    163.636 
  ± 13.002 
 29    178.689 
   ±13.039 
   0.002 
Urinary potassium 
excretion 
11     49.727 
   ± 6.247 
 29      54.038 
    ±7.476 
  0.098 
 
 Of the forty subjects in the hypertensive group ,11 subjects had 
mild  hypertension and 29 subjects had moderate to severe hypertension. 
 In the group with mild hypertension,the average 24 hour urinary 
sodium excretion was 163.636 with a standard deviation of 13.002 . 
In the group with moderate to severe hypertension ,the average 24 
hour urinary sodium excretion was 178.689 with a standard deviation of 
13.039. 
 P value was 0.002 which was significant. 
 
 
The mean 24 hour urinary sodium excretion was higher in patients 
with moderate to severe hypertension when compared to subjects with 
mild hypertension which was statistically significant. 
The average 24 hour urinary potassium excretion in patients with 
mild hypertension was 49.727 with a standard deviation of   6.247. 
The average 24 hour urinary potassium excretion in patients with 
moderate to severe hypertension was 54.038 with a standard deviation of 
7.476.P value was 0.098 which was statistically insignificant. 
 
TABLE 13 
Relationship of 24 hour urinary sodium and potassium excretion with 
severity of diastolic hypertension 
 
         Group 
      Severity of diastolic hypertension  
P value            Mild   Moderate to Severe 
 No Mean±S.D  No Mean ± S.D 
Urinary sodium 
excretion 
25   169.28 ± 
   11.433 
15     183.33 ±  
     15.282 
0.002 
Urinary potassium 
excretion 
25   51.920 ± 
    7.729 
15     54.400 ± 
      6.609          
0.307 
 
 
The average 24 hour urinary sodium excretion in patients with mild  
diastolic hypertension was 169.28 with a standard deviation of 11.433. 
The average 24 hour urinary sodium excretion in patients with 
moderate to severediastolic hypertension was 183.33 with a standard 
deviation of 15.282. 
 P value was 0.002 which was significant.This suggests that there  
was significant increase in 24 hour urinary sodium excretion with 
increasing severity of diastolic hypertension. 
 The average 24 hour urinary potassium excretion in patients with 
mild diastolic hypertension was 51.920 with a standard deviation of 
7.729. 
 The average 24 hour urinary potassium excretion in patients with 
moderate to severe diastolic hypertension was 54.400 with a standard 
deviation of 6.609. 
 P value was 0.307 which was not significant. So, there was no 
significant difference in the 24 hour urinary potassium excretion with 
increasing severity of diastolic hypertension. 
 
 
 
 
 
 
GRAPH 6 
 
  
Relationship of 24 hours urinary sodium excretion
with severity of systolic hypertension
0
50
100
150
200
250
<120 120-139 140-159 160-179 >180
Systolic  BP categories(mmHg)
U
rin
ar
y 
N
a 
ex
cr
et
io
n(
m
m
ol
/d
ay
)
1 2 3 4 5
 
 
 
 
 
GRAPH 7
 
 
  
Relationship of 24 hours urinary Na excretion
 with severity of Diastolic hypertension
0
50
100
150
200
<80         80-89      90-99       >99
Diastolic BP categories(mmHg)
U
rin
ar
y 
N
a 
ex
cr
et
io
n(
m
m
ol
/d
ay
)
1 2 3 4
 
 
TABLE 14 
24 hour urinary sodium excretion by age and sex in the study group 
AGE  GROUP NO    MEAN S.D 
20 - 35 7 158.00 26.134 
36 - 50 40 161.20 15.162 
51 - 70 33 169.85 20.358 
SEX NO MEAN S.D 
Males 42 166.57 16.359 
Females 38 163.29 21.388 
 
 The mean 24 hour urinary sodium excretion in 20 – 35 age group 
was 158 ± 26.134,36 – 50 age group was 161.20 ± 15.162, and 51 – 70 
age group was 169.85 ± 20.36. 
The mean 24 hour urinary sodium excretion in the entire study 
group increased significantly with advancing age which shows the 
influence of age on urinary sodium excretion. 
The mean 24 hour urinary sodium excretion in the entire study 
group was significantly higher in males (166.57 ± 16.359) when 
compared to females (163.29 ± 21.388). 
 
 
TABLE 15 
24 hour urinary sodium excretion in relation to gender in each age group 
in the study population 
       AGE GROUP GENDER NO MEAN 
 
           20 – 35 
Males 3 167 
Females 4 151.25 
 
     36 – 50 
Males 24 162.42 
Females 16 159.38 
 
            51 - 70 
Males 15 170.33 
Females 18 169.44 
 
In age group of 20 – 35,the mean 24hour urinary sodium excretion 
in males was 167 and females was 151.25. 
In age group of 36 – 50, the mean 24hour urinary sodium excretion 
in males was 162.42 and females was 159.38. 
In age group of 51 – 70, the mean 24hour urinary sodium excretion 
in males was 170.33 and females was 169.44. 
In all the age groups,mean 24 hour urinary sodium excretion was 
significantly higher in males as compared to females. 
 
 
TABLE 16 
Relationship of BMI with 24 hours urinary sodium , potassium excretion 
in hypertensives and normotensives 
 
Group 
         BODY MASS INDEX  
   P value      BMI < 25      BMI > 25 
HYPERTENSIVES NO    MEAN NO    MEAN  
Urinary sodium  24    166.67  16    186.38 < 0.001 
Urinary potassium  24    51.58  16      54.75      0.185 
NORMOTENSIVES NO    MEAN NO    MEAN  
Urinary sodium  31    149.87  9    170.11     0.001 
Urinary potassium  31    55.87  9    51.67     0.157 
 
 In hypertensive patients , the mean 24 hour urinary sodium 
excretion in subjects with normal BMI was 166.67 while the mean 24 
hour urinary sodium excretion in subjects with high BMI was 186.38.     
P value was less than 0.001 which was significant. 
 In normotensive subjects,the mean 24 hour urinary sodium 
excretion in subjects with normal BMI was 149.87 while the mean 24 
hour urinary sodium excretion in subjects with high BMI was 170.11.      
P value was 0.001 which was significant. 
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In hypertensive patients , the average 24 hour urinary potassium 
excretion in subjects with normal BMI was 51.58 while the average 24 
hour urinary potassium  excretion in subjects with high BMI was 54.75.           
P value was 0.185 which was not significant. 
 In normotensive subjects ,the average 24 hour urinary potassium 
excretion in subjects with normal BMI was 55.87 while the average 24 
hour urinary potassium excretion in subjects with high BMI was 51.67. P 
value was 0.157 which was not significant. 
 Both the hypertensive and normotensive group showed a 
significant increase in 24 hour urinary sodium excretion in subjects with 
high BMI when compared to normal BMI. 
 There was no significant difference in 24 hour urinary potassium 
excretion between normal and high BMI subjects in both hypertensive 
and normotensive group. 
 This shows that BMI has significant influence on 24 hour urinary 
sodium excretion irrespective of blood pressure level. 
 
 
 
 
TABLE 17 
Correlation between blood pressure and 24 hour urinary sodium excretion 
in hypertensivesafter adjusting for confounding factors 
 
Hypertensives 
        Systolic  BP       Diastolic BP 
       r      p        r       p 
Urinary sodium    0.6372 <0.0001 0.5310 0.0009 
Urinary potassium   -0.3547 0.0338 0.1001 0.5615 
 
 In hypertensive patients,the partial correlation co-efficient ‘r’ was 
0.6372 and p value was less than 0.0001 for correlation between 24hour 
urinary sodium excretion and systolic blood pressure, which was 
statistically significant. 
 The partial correlation co-efficient ‘r’ was 0.5310 and p value was 
0.0009 for correlation between 24 hour urinary sodium excretion and 
diastolic blood pressure ,which was statistically significant. 
 There was significant correlation between 24 hour urinary 
K+excretion ( r = -0.3547,p = 0.0338) and systolic blood pressure while 
there was no significant correlation between diastolic blood pressure and 
24 hour urinary K+ excretion(r=0.1001,p=0.561) in hypertensive patients. 
 
 
DISCUSSION 
 Hypertension is one of the world’s great public health problems 
and leading cause of death. (51) Essential hypertension accounts for about 
90% of all hypertensive patients. (52) 
 Multiple factors are responsible for the development of 
hypertension.One of the causal factors proposed is high sodium intake  
along with low potassium intake and excretion. (2) 
 Our present study was conducted to test this causal relationship 
between sodium,potassium intake and hypertension by measuring 24 hour 
urinary sodium and potassium excretion. 
In our study, the mean 24 hour urinary sodium excretion  was 
significantly elevated in hypertensive group when compared to 
normotensive group which was statistically significant (p value <0.0001).  
Our observation was similar to that recorded in the Intersaltstudy. (3) 
Many other studies have shown excessive 24 hour urinary sodium 
excretion in hypertensive patients. (53) (54) (4) 
 Excessive 24 hour urinary sodium excretion observed in 
hypertensive patients in our study could probably be responsible for the 
development of hypertension which was proved in various other    
 
 
studies. (2) (53) (55) This was further supported by the fact that low salt 
intake reduces hypertension and low prevalence of hypertension in 
population with low salt intake. (55) (56) (57)  
In our study,the average 24 hour urinary potassium excretion was 
lower in both   hypertensive and normotensive groups probably due to 
low potassium intake.Menealy and Belarbee  in 1976 found that low 
potassium intake contributes to hypertension. (2) Various other studies 
have also confirmed that low potassium intake leads to hypertension , 
independent of sodium excretion. (58) (59) 
Excessive 24 hour urinary sodium excretion and lower 24 hour 
urinary potassium excretion in our hypertensive group indicates that both 
high sodium intake and low potassium intake additively contribute to the 
rise in blood pressure.Further urinary Na+/K+ molar ratio was higher in 
hypertensive groups when compared to normotensives which was due to 
increased urinary sodium excretion in hypertensive group as shown in 
various other studies. (4) 
Our study observed significant influence of 24 hour urinary sodium 
excretion on the severity of hypertension.The mean 24 hour urinary 
sodium excretion was significantly higher in patients with severe 
hypertension as compared to mild to moderate hypertension which was 
 
 
statistically significant (p value = 0.002).There was no association 
between 24 hour urinary potassium excretion and severity of 
hypertension.Similar observations were also recorded by RA Jan et al in 
2006. (4) 
In our study, several confounding variables such as age, 
gender,BMI and serum cholesterol were present which could have 
contributed to hypertension apart from the impact of 24 hour urinary 
sodium and potassium excretion.  
Age was the first factor to be independently associated with blood 
pressure .Age influences the capacity of kidneys to conserve sodium. (60) 
Advancing age leads to both a decline in glomerular filtration rate and an 
increased incidence of renal disease (61) which contributes to increased 
urinary sodium excretion in elderly people. (62) This was proved by our 
study which showed a significant increase in 24 hour urinary sodium 
excretion with advancing age.(Table 14) 
Simpson et al in 1978 found that  mean 24 hour urinary sodium 
excretion at all ages was significantly higher in males when compared to 
females. (63) Similar results were obtained in our study which showed a 
higher 24 hour urinary sodium excretion in males as compared to females 
 
 
at all age groups.(Table 15)This could be  probably because of  their 
overall higher food intake and differences in food habits. (64) (65) (66) (67) 
Our study demonstrated a significant impact of BMI on 24 hour 
urinary sodium excretion. In both hypertensive and normotensive 
groups,24 hour urinary sodium excretion increased significantly with 
high BMI.There was no association between urinary potassium excretion 
and BMI in either group.(Table 16) 
 INTERSALT  STUDY has shown significant and independent 
relationship of BMI with hypertension in individual subjects (3) which was 
proved in our study . Simpson et al in 1978 (63) also proved similar 
relationship of BMI with urinary sodium excretion and hypertension as 
observed in our study. 
 The  OLIVETTI  HEART STUDY showed that physiological 
regulation of sodium reabsorption at the proximal tubule was maintained 
in normal weight individuals ; higher the sodium intake,the lower its 
reabsorption at the proximal tubule.In contrast, this physiological 
regulation was found to be altered in overweight/obese individuals , being 
independent of the total amount of sodium ingested.This leads to 
increased urinary sodium excretion in high BMI subjects as observed in 
our study. 
 
 
In our study,the next factor independently associated with blood 
pressure was serum cholesterol ,which has been proved beyond doubt  as 
an independent risk factor for hypertension. (68) 
 The relationship of 24 hour urinary sodium and potassium 
excretion with blood pressure was analysed again after controlling for the 
confounding factors. 
In hypertensive patients, systolic blood pressure correlated 
significantly with 24 hour urinary sodium excretion( r = 0.64, p < 0.0001) 
and 24 hour urinary potassium excretion ( r = -0.35, p = 0.033 ) even after 
adjustment for age, gender,BMI,serum cholesterol. 
In normotensive controls, systolic blood pressure does not correlate 
with 24 hour urinary sodium excretion (r = 0.02, p = 0.92) and potassium 
excretion ( r = 0.19, p = 0.25). 
 In hypertensive patients ,diastolic blood pressure correlated with  
urinary Na+ excretion(r = 0.53,p = 0.0009) but did not correlate with 
urinary K+ excretion( r = 0.10, p = 0.56)  after adjustment for 
age,sex,BMI and serum cholesterol.Similar observation was made by 
B.M.Y.Cheung et al in Chinese population. (47) In normotensive controls, 
diastolic blood pressure did not correlate with urinary Na+ excretion (r = 
0.22, p = 0.19). 
 
 
SUMMARY 
 Forty hypertensive patients and equal  number of age and sex 
matched controls were taken up for studying the relationship between 24 
hour urinary sodium and potassium excretion with blood pressure in 
hypertensive and normotensive subjects at Government Rajaji Hospital, 
Madurai. 
 In hypertensive group , there was significantly elevated 24 hour 
urinary sodium excretion and  Na+/ K+ molar ratio whereas there was 
lower 24 hour urinary potassium excretion.24 hour urinary sodium 
excretion also correlated with severity of hypertension. 
 Age , gender, BMI and serum cholesterol had significant influence 
on 24 hour urinary sodium excretion. 
 Even after adjustment for age, gender,BMI and serum cholesterol, 
24 hour urinary sodium excretion  significantly correlated with both 
systolic and diastolic blood pressure in hypertensive patients. 
24 hour urinary potassium excretion correlated only with systolic 
blood pressure after adjustment for age,gender,BMI and serum 
cholesterol. 
 
 
CONCLUSION 
1.Significantly elevated 24 hour urinary sodium excretion and low 
potassium excretion in our study suggests that both very high sodium 
intake and low potassium intake play a significant role individually as 
well as additively in the development or perpetuation of  hypertension. 
2.BMI and serum cholesterol were strongly ,positively and independently 
associated with blood pressure in individual subjects. 
3.Age and sex have significant influence on urinary sodium excretion and 
blood pressure. 
The final conclusion from our study is that longterm reduction in 
salt intake would significantly reduce the prevalence of hypertension and 
thereby decrease associated morbidity and mortality due to cardiovascular 
disease and stroke.  
 
  
 
 
 
 
 
BIBLIOGRAPHY 
1. Blood pressure insurance experience and its implications. New York 
Metropolitan Life Insurance Company. 1961. 
2. High sodium, low potassium environment and hypertension. Mencely 
GR, Balt HD. s.l. : Am J Cardiol, 1976, Vols. 38: 768 - 85. 
3. An International study of electrolyte excretion and blood pressure, 
results for 24 hour urinary sodium and potassium excretion. Intersalt 
Research Group. s.l. : BMJ, 1988. 
4. Sodium and Potassium Excretion in Normotensive and Hypertensive 
population in Kashmir. RA Jan, S.Shah,SM Saleem,A Waheed,S 
Mufti, MA Lone, M Ashraf . s.l. : JAPI., JANUARY 2006, Vol. 54. 
5. Salt and hypertension. L.K., Dahl. s.l. : Am J Cl Nutrition, 1972, Vol. 
25: 231. 
6. Arterial pressure regulation: Overriding dominance of the kidneys in 
long term regulation and in hypertension. Guyton AD, Coleman TG, 
Cowley AW Jr,Scheel KW,Manning RD, Norman RA. s.l. : Am J 
Med, 1982, Vols. 52: 584 - 94. 
7. The Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation and Treatment of High Blood Pressure:The JNC 7 
report. Chobanian AV, Bakrie GL, Black HR et al. s.l. : JAMA, 2003, 
Vols. 289: 2560 - 72. 
8. Arterial and venous compliance in obese and non - obese subjects. 
Oren S, Grossman E, Frohlich ED. s.l. : Am J Cardiol, 1996, Vols. 77 : 
665 - 776. 
9. Physiological and metabolic consequences of obesity. E., Ferrannini. 
1995, Metabolism, Vol. 9, pp. 15-7. 
 
 
10. Clustering of dyslipidemia, hyperuricemia, diabetes and hypertension 
and its association with fasting insulin and central and overall obesity in a 
general population. Schmidt MI, Watson RL, Duncan BB et al. s.l. : 
Metabolism, 1996, Vols. 45:699 - 706. 
11. The vasodilator action of insulin implications for the insulin 
hypothesis of hypertension. Anderson EA, Mark AL. s.l. : 
Hypertension, 1993, Vols. 21: 136 - 41. 
12. Salt intake and plasma arterial natriuretic peptide and nitric oxide in 
hypertension. Campese VM, Tawadrous M, Bigezzi R et al. s.l. : 
Hypertension, 1996, Vols. 28: 335 - 40. 
13. Renal function and blood pressure response to dietary salt restriction 
in normotensive men. Barba G, Cappuccio FP, Russ L et al. s.l. : 
Hypertension, 1996, Vols. 27: 1160-4. 
14. Sodium proton exchange and primary hypertension. Stiffert W, 
Dusing R. s.l. : Hypertension, 1995, Vols. 26: 649 - 55. 
15. Predominance of nocturnal sympathetic nervous activity in salt 
sensitive normotensive subjects. Yo Y, Nagano M, Moriguchi A et al. 
s.l. : Am J Hypertens, 1996, Vols. 9: 726 - 31. 
16. Effect of l-arginine on systemic and renal hemodynamics in salt 
sensitive hypertension. Campese VM, Mann A, Wuzgaft A. s.l. : J Am 
SoC N eghool, 1996, Vol. 7: 1547. 
17. Intercellular ionic consequences of dietary salt loading in essential 
hypertension. Resnick LH, Gupta RK, Difabio B et al. s.l. : J Clin 
Invest, 1994, Vols. 94: 1269 - 74. 
18. Definitions and characteristics of sodium sensitivity and blood 
pressure resistance. Weinberger NH, Miller JZ et al. s.l. : Hypertension, 
1986, Vols. 8(Suppl II): 127 - 134. 
19. Enhanced blood pressure response to dietary salt in elderly 
woman,especially those with small waist hip ratio. Nestel RJ, Clifton 
PM, Noakes M et al . s.l. : J Hypertens, 1993, Vols. 11: 1387 - 94. 
 
 
20. The dominant role of the kidneys in longterm arterial pressure 
regulation in normal and hypertensive states. Guyton A, Hal J, Coleman 
T , et al.l. New York , Raven Press, s.l. : Htpertension: Pathophysiology, 
Diagnosis and Management, Vol. 2. 
21. The Kidney, hypertension and obesity. E, Hall. s.l. : Hypertension, 
Vols. 41: 625 - 633. 
22. The renin - angiotensin - aldosterone system for the normal regulation 
of blood pressure and sodium and potassium homeostasis. Sealey JE, 
Laragh JH. New York Raven Press, s.l. : Hypertension:Pathophysiology, 
diagnosis and Management, 1995, Vols. 1769 - 1797. 
23. Handbook of Physiology,Renal physiology. :, Windhager EE. Vols. 
2: 1409 - 1541. 
24. Mechanisms of pressure natriuresis. Granger JP, Alexander 
BT,Llinas. s.l. : Curr Hypertens, 2002, Vols. 4: 152 - 159. 
25. Role of renal interstitial hydrostatic pressure in the pressure diuresis 
response. Gracia Eston J, Roman RJ. s.l. : AmJ Phsiol , 1989:256. 
26. The role of the kidney in hypertension. Cowley AW Jr, Roman RJ. 
s.l. : JAMA, Vols. 275: 1581 - 1589,1996. 
27. High - salt diet increases sensitivity to NO and eNOS expression but 
not NO production in THALs. Ortiz p, stoos BA, HongNJ et al. s.l. : 
Hypertension, 2003, Vols. 41: 682 - 687. 
28. Importance of the renal medullary circulation in the control of sodium 
excretion and blood pressure. DL, Mattson. s.l. : Am J Physiol, 2003, 
Vols. 284: R13 - R27. 
29. Sodium transport inhibitors and hypertension. de Wardener HE, 
Franz Volhard lecture. s.l. : J Hypertens, 1996, Vols. 14 (Suppl 5): S9 - 
S18. 
30. Glomeruli and blood pressure.Less of one, more of other. Brenner 
BM, Gracia DL,Anderson S. s.l. : Am J Hypertens, 1988, Vols. 1: 335 - 
47. 
 
 
31. Congenital oligonephropathy and the etiology of adult hypertension 
and progressive renal injury. Brenner BM, Chestow GM. s.l. : Am J 
Kidney Dis, 1994, Vols. 23: 171-5. 
32. Endogenous oubain: Role in the pathogenesis of hypertension. MP, 
Blaustein. s.l. : Kidney Int, 1996, Vols. 49: 1748 - 53. 
33. The renin system and four lines of hypertension research. JH, 
Laragh. s.l. : Hypertension, 1992, Vols. 20: 267-79. 
34. On the renal basis of essential hypertension: nephron heterogeneity 
with discordant renin secretion and sodium excretion causing a 
hypertensive vasoconstriction volume relaxation. Sealey JE, Blumenfeld 
JD, Bell GM et al. s.l. : J Hypertens, 1988, Vols. 6: 763-77. 
35. Non - modulation hypertension. A subset of sodium sensitive 
hypertension. Williams GH, Hollenberg NK. s.l. : Hypertension, 1991, 
Vols. 17(Suppl 1): 181 - 185. 
36. Essential hypertension as an endocrine disease. ., Williams GH. s.l. : 
Endocr Metab Clin North Am , 1994, Vols. 23: 429 - 44. 
37. Role of II b hydroxysteroid dehydrogenase type 2 in blood pressure 
regulation. Ferrari P, Krozowski Z. s.l. : Kidney Int, 2000, Vols. 57: 
1374 - 81. 
38. The role of the II hydroxygenase type 2 in human hypertension. 
Ferrari P, Lovati E, Frey FJ. s.l. : Journal of Hypertension, 2000, Vols. 
18: 241 - 8. 
39. Role of the renin angiotensin aldosterone axis in human hypertensive 
disorders. JH, Laragh. s.l. : The Kidney in Hypertension. Raven Press, 
New York. , 1987, Vol. p3 552. 
40. Structural versus functional modulation of the arterial baroreflex. . 
Chapleau MW, Cunningham JT, Sullivan MJ et al. s.l. : 
Hypertension, 1995, Vols. 26: 341 - 7. 
41. Increased systemic vascular resistance and primary hypertension: 
expanding complexity. JT., Shepherd. s.l. : J Hypertens, 1990, Vols. 
8(suppl 7): 815 - 827. 
 
 
42. Hypothesis : The role of acquired tubulointerstitial disease in the 
pathogenesis of salt dependent hypertension. Johnson RJ, Schreiner 
GF. s.l. : Kidney Int, 1997, Vols. 52: 1169 - 79. 
43. Kidney, salt and hypertension.How and why. K, Kurokowa. s.l. : 
Kidney Int, 1996, Vols. 49(Suppl 55): S46 - S51. 
44. The evidence for a pathophysiologic significance of the sympathetic 
overactivity in hypertension. S., Julius. s.l. : Clin Exp Hypertens, 1996, 
Vols. 18: 305 - 21. 
45. Relationship of urinary sodium and sodium to potassium ratio to 
blood pressure in older adults in Australia. Catherine E Huggins, 
Sharleen O' Reilly, Maree Brinkman, Allison Hodge, Graham G 
Giles, Dallas R English and Caryl A Nowson. s.l. : Med J Aust , 2011, 
Vols. 195(3): 128 - 132. 
46. Estimation of salt intake by 24h urinary sodium excretion in a 
representative sample of spanish adults. Rosa M Ortega, Ana M Lopez-
Sobaler, Juan M.Ballesteros, Napolean Perez-Farinos, Elena 
Radriguez-Radriguez, Aranzazu Aparicio, Jose M . Perera and 
Pedro Andres. s.l. : British Journal of Nutrition., 2010, Vols. p1-7. 
47. Diastolic blood pressure is related to urinary sodium excretion in 
hypertensive chinese patients. B.M.Y.CHEUNG, S.P.C, 
A.H.K.CHEUNG and C.P.LAU. s.l. : QJ Med , 2000, Vols. 93: 163 - 
168. 
48. Urinary sodium and potassium excretion and risk of hypertension in 
Chinese: report from a Community - based Cohort study in Taiwan. Kuo 
-Liong Chien, Hsiu-Ching Hsu, Pei-Chunchen, Ta-Chen Su, Wei-
Tien Chang, Ming- Fong Chen and Yuan-Teh Lee. s.l. : Journal of 
Hypertension, 2008, Vols. 26: 1750-1756. 
49. The effects of familial relationships, age, body weight, and diet on 
blood pressure and the 24 hour urinary excretion of sodium, potassium, 
and creatinine in men, women and children of randomly selected families. 
Sonja L.Connor, William E.Connor, Holly Henry, Gary Sexton and 
Edward J.Keenan. s.l. : Circulation , 1984, Vols. 70, No .1, 76 - 85. 
 
 
50. Association of urinary sodium/Potassium Ratio with blood 
pressure:Sex and Racial differences. S.Susan Hedayati, Abu 
T.Minhajuddin, Adeeljaz, Oreon W.Moe, Essam F.Elsayet, Robert 
F.Reilly, Chou-Long Huang. s.l. : CJASN February, 2012, Vols. 7 no.2, 
315 - 322. 
51. The World Health Report: Reducing risks, Promoting Healthy Life. 
B, Campini. Geneva, WHO : s.n., 2002. 
52. Prevalence of primary and secondary hypertension studies in a 
random population sample. L., Berglund G Anderson O.Wellebmsa. 
s.l. : Br Med Jr, 1976, Vol. 2: 554. 
53. Sodium and hypertension in nutrition and cardiovascular disease. 
Joosens JV, Williams J.Classens J et al. s.l. : Morgagni Edizioni 
Scientifichi Rome., Vols. 197: 91-110. 
54. Renal functioning normal and hypertensive 50year old male. al, 
Berglund et. s.l. : Acta Med Scand, 1976, Vol. 199:25. 
55. Treatment of Hypertensive vascular disease with rice diet. W., 
Kempner. s.l. : Am J Medicine, 1948, Vol. 4: 545. 
56. Salt in hypertension and the effects of diuretics. ED., Fries. s.l. : Am 
Rev Pharmacology Toxicol, 1979, Vols. 19: 13-23. 
57. Hypertension treated by salt restriction. Morgen TAW, Gllies 
WMH. s.l. : Lancet, 1979, Vols. 1:227-30. 
58. The use of Sodium chloride, potassium chloride, sodium bromide and 
potassium bromide on cases of arterial hypertension which are to 
potassium chloride. . WLT., Addison.  : Can Med Assoc Jr, 1928, Vols. 
18:281-5. 
59. Double blind randomised crossover trial of moderate sodium 
restriction in essential hypertension. al., Macgreger GA et. s.l. : Lancet, 
1982, Vols. 1: 351-5. 
60. Age is a determinant of renal sodium conservation in man. H., Muray 
E .Norman. s.l. : J Lab Clin Inv, 1975. 
 
 
61. Abnormalities of water metabolism in the elderly. AI, Ayus JC & 
Arieff. s.l. : Semin Nephrol, Vols. 16, 277-288. 
62. Electrolyte and salt disturbances in older people: causes, management 
and implications. Soiza RL, Graeme E & Chua M. s.l. : Rev Clin 
Gerontol, 2008, Vols. 18, 143 - 158. 
63. Relationship of blood pressure to sodium excretion in a population 
survey. Simpson FO, Wattal Manning HJ, et al. s.l. : Clin Science and 
Mol Med, 1978, Vols. 55: 373 - 5. 
64. Salt intakes around the world: implications for public health 
International. Brown IJ, Tzoulaki I, Candeias V, et al. s.l. : J 
Epidemiol, 2009, Vols. 38, 791 - 813. 
65. Salt and the metabolic syndrome. Lx, Hoffman IS & Cubeddu. s.l. : 
Nutr Metab Cardiovasc Dis, 2009, Vols. 19, 123 - 128. 
66. Sodium in the finnish diet: 20 year trends in urinary sodium excretion 
among the adult population. Laatikainen T, Pietinen P, Valsta L, et al. 
s.l. : Eur J Clin Nutr, 2006, Vols. 60, 965 - 970. 
67. INTERMAP Research Group.Nutrient intakes of middle aged men 
and women in China, Japan,United Kingdom, and United States in the 
late1990s: the INTERMAP study. Zhou BF, Stamler J , Dennis B, et al. 
s.l. : J Hum Hypertens , 2003, Vols. 17, 623 - 630. 
68. Atherosclerosis and other forms of arteriosclerosis. P., Libby. s.l. : 
Harrison's Principle of Internal Medicine, McGraw Hill,15th edition., 
2001, Vols. 18: 1377 - 86. 
69. Blood pressure insurance experience and its implications. New York 
Metropolitan Life Insurance Company,. 1961. 
70. Sodium and Potassium Excretion in Normotensive and Hypertensive 
Population in Kashmir. RA Jan, S.Shah, SM Saleem, A Waheed, S 
Mufti,MA Lone, M Ashraf. JANUARY 2006, JAPI., Vol. 54. 
71. Renal functioning normal and hypertensive 50year old male. al, 
Berglund et. s.l. : Acta Med Scand, 1976, Vol. 199:25. 
 
 
ABBREVIATIONS      
RAAS - Renin – angiotensin – aldosterone system 
A II  - Angiotensin II     
RIHP  -  Renal interstitial hydrostatic pressure 
GFR  -  Glomerular filtration rate 
FSA  -  Filtration surface area 
HT  -  Hypertension 
AME   - Apparent mineralocorticoid excess 
Na+   -  Sodium 
K+  -  Potassium 
RKKS - Renin – kallikrein – kinin system  
GRA  - Glucocorticoid Remediable Aldosteronism 
SVR  - Systemic vascular resistance 
RSNA - Renal sympathetic nerve activity  
 
 
 
 
 PROFORMA  
NAME : 
AGE     : 
SEX      : 
OCCUPATION : 
ADDRESS : 
SYMPTOMS : 
Head ache   Chest pain    Weakness            Swelling over legs 
Dizziness   Breathlessness   Weight gain          Excessive sweating 
Fatigue   Visual problems   Tremors   Decreasedurineoutput 
Palpitation   Abdominal mass   Facial puffiness Heat/cold intolerance 
PAST ILLNESS: 
Hypertension – duration,levels of elevated blood pressure 
Diabetes 
Coronary artery Disease /Cerebrovascular accident 
 
 
 
FAMILY HISTORY : 
Hypertension 
Diabetes 
Coronary artery disease/Cerebrovascular accident 
Renal disease 
PERSONAL HISTORY : 
Smoking  
Alcohol intake 
DRUG HISTORY : 
All prescribed and over the counter medications 
GENERAL EXAMINATION 
ANTHROPOMETRY : 
Height : 
Weight : 
BMI : 
 
 
 
Anaemia/Jaundice/Cyanosis/Clubbing/Facial puffiness/Pedal edema 
Arcus senilis/Xanthelesma/Xanthomas 
Thyroid swelling 
Fundus examination 
VITALS 
Pulse : 
BP : 
JVP : 
SYSTEMIC EXAMINATION  
CVS : 
RS : 
ABDOMEN : 
CNS : 
INVESTIGATIONS 
Urine – albumin, sugar, deposits 
Blood – sugar , urea, creatinine 
 
 
Serum – sodium , potassium 
Lipid profile – TGL, LDL, HDL, Cholesterol 
Serum – calcium, phosphorus 
Serum – uric acid 
24 hours urinary excretion of sodium and potassium 
Thyroid profile 
Chest Xray PA view 
Electrocardiogram 
Echocardiography 
USG Abdomen and pelvis 
 Patients were evaluated on the basis of proforma of above 
guidelines. 
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1  35  Male  25.56  142  3.5  9.4  3.6  198  102 24  0.8  5.6  180 56  178  100 
2  42  Male  25.53  143  3.6  10  3.8  200  98  26  0.9  5.7  178 46  164  96 
3  45  Male  22.82  139  3.8  9.3  3.5  194  97  32  0.9  5.8  148 60  150  94 
4  45  Male  21.88  137  3.9  9.4  3.7  188  110 34  0.5  6.2  158 62  168  100 
5  68  Female  25.96  146  3.6  10.2  4.1  198  98  36  1  6.4  198 58  180  106 
6  45  Female  23.89  142  3.7  9  4.2  186  98  42  0.9  6.5  175 43  146  98 
7  52  Male  26.14  142  4.1  9.4  4  220  96  40  0.8  5.5  178 55  166  96 
8  44  Male  27.06  143  3.5  9.2  3.9  210  95  25  0.7  5.4  172 60  162  94 
9  46  Male  27.16  145  3.8  10.2  3.5  200  104 35  1.5  5.3  190 46  158  98 
10  36  Male  19.15  135  3.7  9.1  3.7  179  96  41  1.3  5.2  168 62  164  94 
11  50  Female  22.66  138  3.9  9.5  3.8  186  97  44  0.5  5.5  178 50  156  96 
12  67  Female  30.46  144  4.2  9.1  3.5  245  98  38  1.5  5.4  220 54  180  108 
13  55  Male  22.46  143  3.8  9.2  3.5  186  115 36  0.6  6.2  164 69  162  92 
14  55  Female  24.81  136  3.7  10  4  188  120 23  0.8  5.6  157 44  154  94 
15  57  Female  24.47  134  4.3  9.3  3.6  194  98  43  0.7  6.3  164 56  158  96 
16  66  Male  23.28  135  3.6  9.3  3.7  184  96  41  0.9  5.5  168 41  162  94 
17  57  Female  23.63  134  3.5  9.6  3.8  188  94  26  1.5  5.4  166 58  166  92 
18  40  Male  23.79  136  3.8  11  3.9  186  97  22  1.3  5.6  157 43  156  94 
19  46  Male  22.14  145  4.5  10.5  3.5  179  113 28  1.6  5.5  169 46  168  100 
20  42  Male  22.35  139  3.5  9.5  3.5  177  120 29  1.2  5.4  156 59  156  94 
 
 
 
21 38 Male 24.37 137 4.5 9.4 4.1 183 115 36 0.8 5.8 166 47 166 96
22 49 Male 22.58 146 3.8 9.4 4.4 186 130 32 0.7 5.7 148 46 146 92
23 49 Male 32.25 143 3.7 9.2 3.8 240 97 33 0.9 6.8 185 65 178 108
24 53 Female 23.43 134 3.6 9.6 3.7 192 98 38 0.8 5.8 195 43 174 96
25 36 Male 22.36 142 4.4 9.1 3.4 186 97 44 0.8 6.4 167 48 148 94
26 55 Female 23.04 137 3.9 9 3.4 194 112 46 1.3 6.6 160 52 154 96
27 63 Female 25.32 144 4.8 10.4 3.6 197 115 45 0.9 6.8 172 56 166 98
28 60 Female 25.74 145 3.5 10.2 3.8 198 98 32 0.9 5.4 182 44 176 104
29 46 Female 21.81 134 3.8 9.3 4.1 175 97 43 1 5.8 166 48 172 100
30 55 Female 25.2 143 5 9.4 4.5 197 96 40 1.2 5.9 196 52 180 104
31 55 Male 25.64 146 3.6 9.3 4.5 194 95 41 1 6.2 188 62 178 106
32 65 Male 20.33 136 3.8 10.1 3.8 174 104 39 1 5.8 176 50 168 98
33 50 Male 24.16 145 3.7 9.4 3.5 192 112 38 0.9 5.8 175 65 176 96
34 68 Male 22.14 138 3.9 9.4 3.6 182 99 37 1 5.7 175 52 168 100
35 64 Female 25.57 144 4 9.7 3.5 197 96 37 0.8 5.6 180 53 176 98
36 30 Female 25.7 141 3.5 9.2 3.6 198 114 38 0.9 6.4 184 50 180 108
37 38 Female 22.36 137 4.1 9 3.6 178 130 42 0.8 7.1 170 48 166 100
38 45 Female 23.05 139 3.8 9 3.4 184 112 44 1.2 7.5 174 46 172 98
39 25 Male 26.09 143 3.9 10.3 3.5 196 98 40 0.9 6.8 185 63 178 100
40 52 Female 25.74 145 4.8 11 3.6 191 99 38 1.5 6.4 194 56 186 100  
 
 
 MASTER CHART – CONTROLS: NORMOTENSIVE SUBJECTS 
 
41 45 Male 24.28 135 3.6 9 3.5 184 120 33 0.9 6.4 174 58 118 74
42 44 Male 22.89 141 3.4 8.5 3.6 174 112 32 0.8 6.2 168 65 116 72
43 52 Male 25.95 140 4.2 9.6 3.5 193 103 30 1.3 5.8 184 48 120 80
44 44 Female 21.69 139 4.6 8.7 3.5 176 98 28 0.9 5.6 169 63 116 76
45 63 Male 24.06 146 3.5 8.8 3.4 182 96 26 1 5.4 165 67 114 78
46 37 Female 21.81 138 3.7 8.9 3.4 195 95 25 1.2 5.6 148 46 110 70
47 54 Male 24.37 135 3.9 9.3 3.8 174 113 34 1 5.5 166 58 114 76
48 38 Female 22.92 138 3.6 9.5 3.7 178 104 36 0.5 7.2 158 58 116 72
49 48 Male 23.42 142 3.8 10 4 181 95 38 1.5 6.5 164 48 118 78
50 41 Female 22.92 140 3.6 11 4.2 178 96 25 0.8 8 166 64 116 78
51 48 Female 22.22 138 3.5 9 4.2 178 104 28 0.7 5 155 52 112 76
52 64 Male 23.05 137 4.2 8.8 3.6 184 110 29 1.2 6.4 168 68 116 74
53 65 Male 22.66 141 3.6 8.9 3.5 174 104 34 0.9 6.2 136 56 112 76
54 57 Male 26.02 136 4.3 9.1 3.6 196 99 36 1.5 5.6 183 48 120 82
55 58 Female 22.08 143 3.5 9.3 3.6 184 103 38 0.9 5.8 148 58 110 74
56 43 Male 22.68 137 3.6 9.5 3.7 179 114 44 0.8 5.5 138 44 112 76
57 58 Female 21.34 136 3.7 9.7 3.8 198 103 42 0.9 5.7 128 68 100 68
58 42 Female 21.05 137 3.8 9.8 3.5 175 98 40 0.7 5.6 146 45 118 78
59 40 Male 21.65 138 3.5 8.7 3.6 173 96 36 1.3 5.8 134 48 114 76
60 63 Male 26.72 135 3.5 8.9 3.6 188 98 38 1.4 6.2 182 63 124 86  
 
 
 
 
 
 
 
61  34  Female  20.09  136  3.8  8.9  3.4  165  104 46  0.9  5.6  118 49  110  76 
62  46  Male  22.89  138  3.7  9.2  3.5  192  110 48  0.8  4.8  148 57  114  78 
63  58  Female  25.95  141  3.8  9.4  3.6  196  98  47  0.5  5.7  155 67  120  86 
64  48  Male  27.79  138  3.6  9.5  3.6  194  98  40  0.5  5.6  195 46  116  88 
65  47  Female  22.36  139  4.4  10.4  3.4  180  110 36  0.8  5.9  153 49  126  80 
66  45  Female  23.94  138  4.3  9.8  3.8  178  97  35  0.6  6.2  164 53  118  78 
67  48  Male  26.81  143  3.7  11  4.2  196  98  34  0.6  4.4  158 47  122  84 
68  38  Female  22.22  139  3.8  9.3  4.5  168  98  36  1  5.8  148 59  112  76 
69  48  Male  21.65  135  3.9  9.5  4.1  165  99  44  1.2  6.4  159 46  100  74 
70  54  Female  23.05  136  3.6  10.1  3.6  170  104 26  0.5  5.8  123 54  120  80 
71  45  Male  26.45  145  3.7  11  3.5  191  103 42  1  3.6  164 55  126  84 
72  36  Female  22.08  138  3.5  9  3.6  168  112 40  0.9  5.6  144 57  118  80 
73  31  Male  23.79  137  3.8  9.4  3.8  198  106 23  0.8  5.8  136 56  114  76 
74  36  Male  23.05  141  3.7  9.6  3.5  188  105 24  0.9  6.2  127 64  108  74 
75  34  Female  23.42  135  3.6  9.5  3.4  162  104 25  1.3  5.5  156 57  110  70 
76  63  Female  26.51  136  3.5  9.6  3.5  210  105 20  0.8  5.6  156 47  124  86 
77  62  Male  26.47  138  3.9  9.4  4.2  230  98  41  0.9  5.8  154 44  128  86 
78  46  Female  21.52  136  3.8  9.5  3.6  176  97  42  0.8  6.2  136 48  116  78 
79  20  Female  22.09  135  4  9.2  3.6  175  96  36  0.7  5.5  147 69  114  74 
80  54  Female  23.28  135  4.2  9.3  3.5  180  95  22  0.9  5  156 48  118  80 
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